Legionella Pneumophila and Dendrimers-Mediated Antisense Therapy

Roghiyeh Pashaei-Asl ^1,2,3, Khodadad Khodadadi ⁴, Fatima Pashaei-Asl ⁵, Gholamreza Haqshenas ⁶, Nasser Ahmadian ⁷, Maryam Pashaiasl ^8,9 * , Reza Hajihosseini Baghdadabadi ¹ *

Cited by CrossRef: 6

1- Pashaei-Asl F, Pashaei-Asl R, Khodadadi K, Akbarzadeh A, Ebrahimie E, Pashaiasl M. Enhancement of anticancer activity by silibinin and paclitaxel combination on the ovarian cancer. Artificial Cells, Nanomedicine, and Biotechnology. 2018;46(7):1483 [Crossref]

2- Mignani S, Shi X, Zablocka M, Majoral J. Dendrimer-Enabled Therapeutic Antisense Delivery Systems as Innovation in Medicine. Bioconjugate Chem. 2019;30(7):1938 [Crossref]

3- Wang Y, Sun H. Polymeric Nanomaterials for Efficient Delivery of Antimicrobial Agents. Pharmaceutics. 2021;13(12):2108 [Crossref]

4- Gattuso G, Rizzo R, Lavoro A, Spoto V, Porciello G, Montagnese C, Cinà D, Cosentino A, Lombardo C, Mezzatesta M, Salmeri M. Overview of the Clinical and Molecular Features of Legionella Pneumophila: Focus on Novel Surveillance and Diagnostic Strategies. Antibiotics. 2022;11(3):370 [Crossref]

5- Reuter C, Slesiona N, Hentschel S, Aehlig O, Breitenstein A, Csáki A, Henkel T, Fritzsche W. Loop-mediated amplification as promising on-site detection approach for Legionella pneumophila and Legionella spp.. Appl Microbiol Biotechnol. 2020;104(1):405 [Crossref]